Announcement! Late-breaking abstracts are now being accepted for the MGFA 15th International Conference on Myasthenia Gravis and Related Disorders. Late-breaking abstracts must have key aspects of research conducted after the original November 15, 2024 abstract submission deadline. These abstracts must be new and of sufficient scientific importance to warrant expedited presentation and publication and contain timely, significant, and innovative content. Case reports are not acceptable submissions and will not be considered. For more information and to submit a late-breaking abstract, visit https://lnkd.in/dmgbRH6U.
Myasthenia Gravis Foundation of America, Inc.’s Post
More Relevant Posts
-
📣 Looking back at some of the important RefluxStop™ data that was published through 2024. In July, did you see the article, "Cost-effectiveness of the RefluxStop™ device for management of refractory gastroesophageal reflux disease in Switzerland," in the Journal of Medical Economics? Don't worry if you missed it, read the article here: https://lnkd.in/g4Zt-cNA 🗞️ Read more RefluxStop™ studies at our Scientific Publications & Abstracts page: https://lnkd.in/gp3vGV3Y
-
-
📣 Looking back at some of the important RefluxStop™ data that was published through 2024. In July, did you see the article, "Cost-effectiveness of the RefluxStop™ device for management of refractory gastroesophageal reflux disease in Switzerland," in the Journal of Medical Economics? Don't worry if you missed it, read the article here: https://lnkd.in/g4Zt-cNA 🗞️ Read more RefluxStop™ studies at our Scientific Publications & Abstracts page: https://lnkd.in/gp3vGV3Y
-
-
We are pleased to announce the publication of Volume 2 of “Medicine & Science Journal” (MSJ) An international open access journal encompassing both experimental and clinical science, MSJ provides a high-level platform featuring original articles, meta-analyses, case reports, and editorials on topics of medical and scientific relevance. This new issue marks another step forward in the dissemination of knowledge and the exploration of current challenges in medicine and science. Discover the full content in Volume 2: https://lnkd.in/d9bJhazC
-
-
Explore the recent interview series in which Lan Coffman, MD, PhD, discusses the results and clinical implications derived from the findings of the Phase III MIRASOL trial. Watch now: bit.ly/4it13VP
-
-
Explore the recent interview series in which Lan Coffman, MD, PhD, discusses the results and clinical implications derived from the findings of the Phase III MIRASOL trial. Watch now: bit.ly/4it13VP
-
-
Dear friends and colleagues, To date very few journals publish video articles in our field, despite this type of article being of paramount importance for sharing techniques and improving their replicability. For this reason, I have opened a Methods Collection with JoVE on “Current Methods for Evaluating Cardiac Damage and Promoting Repair Following Ischemic Heart Disease”: https://lnkd.in/dquTHUH5 Authors submit a traditional text manuscript, after which JoVE handles all the video production. If you are interested in contributing a video article on your methods, either message me or submit an abstract here: https://lnkd.in/dquTHUH5
-
Dr. Abdullah Al Maruf from University of Manitoba is editing an issue on the clinical implementation of pharmacogenomics. Learn more about this new issue and submit your paper before 25th December: 🔗https://lnkd.in/db53BvSC
-
-
Nothing more pleasant as MD supervisor than seeing a new-born publication. Well done Dr Mitchell et al on the new publication in the BMJ journals as part of your work on ovarian masses. In this case report the recurrent tumour identified was initially 10 mm, similar to previous studies. However, the rate of growth for the cyst demonstrated here was 2.4 mm, which is higher than previously reported. We also observed the cyst wall to solid component growth ratio which was an almost equal ratio of 1 mm:1.09 mm. So proud https://lnkd.in/er2vKXJA https://lnkd.in/ezHBU685 https://lnkd.in/eZqeF-DD
-
-
Typically, physicalism measures time in the binary mode, while phenomenology focuses on its meaning. Here, we show how to measure various atypical phenomena of the meaning of time across 7 dimensions of temporal experience, each in three aspects. Great work by Anastazja Szuła supported by Giovanni Stanghellini and myself published in Journal of Clinical Medicine (JCM) MDPI). This structured phenomenological interview is ready to use and validated for the Polish language. Sponsored by NCN National Science Centre, Poznan University of Medical Sciences, Heidelberg University PS. On the figure lovely correlations across dimensions in the "normal" population - stay tuned for the "disturbances"!
-
-
I am so excited to share that our latest mixed-methods study has been published in Frontiers in Medicine! In this paper, my colleagues (Rudmila-Rodica Ivan, Colleen Robb & Jillian Derby) and I report the results of our meticulous research into the factors that impact response scores in Casper, an open-response situational judgment test. Curious to find out more? Here’s the link to our paper! https://lnkd.in/gfyuKJag Happy reading! 😊
